Top Broker Regulation Stories
Ozempic and Wegovy manufacturers accused of downplaying drugs' risks
By Riley BrennanThe complaint further alleges the defendants knew of the association between GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues but ignored the association and failed to disclose the information they possessed.









